PL4247335T3 - Kompozycja farmaceutyczna zawierająca kannabidiol i kwas hialuronowy - Google Patents

Kompozycja farmaceutyczna zawierająca kannabidiol i kwas hialuronowy

Info

Publication number
PL4247335T3
PL4247335T3 PL21815896.2T PL21815896T PL4247335T3 PL 4247335 T3 PL4247335 T3 PL 4247335T3 PL 21815896 T PL21815896 T PL 21815896T PL 4247335 T3 PL4247335 T3 PL 4247335T3
Authority
PL
Poland
Prior art keywords
cannabidiol
pharmaceutical composition
hyaluronic acid
hyaluronic
acid
Prior art date
Application number
PL21815896.2T
Other languages
English (en)
Inventor
Jan STORCH
Lenka PRUSOVA
Original Assignee
Cb21 Pharma, S.R.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cb21 Pharma, S.R.O. filed Critical Cb21 Pharma, S.R.O.
Publication of PL4247335T3 publication Critical patent/PL4247335T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL21815896.2T 2020-11-19 2021-11-17 Kompozycja farmaceutyczna zawierająca kannabidiol i kwas hialuronowy PL4247335T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2020620 2020-11-19
PCT/CZ2021/050136 WO2022105952A1 (en) 2020-11-19 2021-11-17 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
PL4247335T3 true PL4247335T3 (pl) 2025-05-12

Family

ID=78819206

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21815896.2T PL4247335T3 (pl) 2020-11-19 2021-11-17 Kompozycja farmaceutyczna zawierająca kannabidiol i kwas hialuronowy

Country Status (7)

Country Link
US (1) US20230355645A1 (pl)
EP (1) EP4247335B1 (pl)
AU (1) AU2021384650A1 (pl)
CA (1) CA3191976A1 (pl)
ES (1) ES3023559T3 (pl)
PL (1) PL4247335T3 (pl)
WO (1) WO2022105952A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240116462A (ko) 2021-10-26 2024-07-29 더 유니버시티 오브 뉴캐슬 대마 추출물로 난소암을 치료하는 방법
CA3235077A1 (en) 2021-10-26 2023-05-04 Alex Nance Systems and methods for producing hemp extracts and compositions
AU2022379618A1 (en) 2021-10-26 2024-05-23 Dove Innovation Pty Limited Methods of treating endometriosis and other non-cancer gynecological disorders with hemp extract
US12097211B2 (en) 2022-10-26 2024-09-24 Ecofibre USA Inc. Methods of treating estrogen sensitive diseases with cannabis extract
US12011451B2 (en) 2022-10-26 2024-06-18 Ecofibre USA Inc. Stabilized compositions comprising cannabidiol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10092538B2 (en) * 2016-10-21 2018-10-09 Axim Biotechnologies, Inc. Suppositories comprising cannabinoids
US10751299B2 (en) 2018-09-04 2020-08-25 Babak Ghalili Cannabinoid and menthol compositions and methods

Also Published As

Publication number Publication date
WO2022105952A1 (en) 2022-05-27
EP4247335A1 (en) 2023-09-27
AU2021384650A9 (en) 2025-04-03
EP4247335B1 (en) 2025-02-12
CA3191976A1 (en) 2022-05-27
EP4247335C0 (en) 2025-02-12
ES3023559T3 (en) 2025-06-02
US20230355645A1 (en) 2023-11-09
AU2021384650A1 (en) 2023-05-11

Similar Documents

Publication Publication Date Title
PL4247335T3 (pl) Kompozycja farmaceutyczna zawierająca kannabidiol i kwas hialuronowy
EP4183391A4 (en) PHARMACEUTICAL COMPOSITION AND USE THEREOF
ZA202206370B (en) Novel hyaluronic acid-hydrolyzing enzyme variant having improved stability and pharmaceutical composition comprising same
EP3600563C0 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING VITAMIN D3 AND HYALURONIC ACID
IL263174A (en) Preparations containing cannabidiol and hyaluronic acid for the treatment of inflammatory joint diseases
IL320856A (en) Pharmaceutical combinations and their uses
UY33076A (es) Microcápsulas de fexofenadina y composiciones que las contienen
ZA202105586B (en) Pharmaceutical delivery compositions and uses thereof
GB2611642B (en) Pharmaceutical and cosmetic compositions comprising secretomes
EP4112082A4 (en) DRUG DELIVERY COMPOSITION CONTAINING CROSS-LINKED HYALURONIC ACID AND METHOD FOR THE PRODUCTION THEREOF
EP4101860A4 (en) HYALURONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION AND MEDICINE CONJUGATE - HYALURONIC ACID DERIVATIVE -
PT4153133T (pt) Composições farmacêuticas injetáveis e utilizações das mesmas
IL289943A (en) Medicinal and/or pharmaceutical compositions for insertion into a blister, preparation and uses
BR112012021445B8 (pt) formulação farmacêutica ou neutracêutica, e uso de um agente promotor de biodisponibilidade
PH12021550090A1 (en) Composition comprising glycyrrhizin and cosmetic and pharmaceutical uses thereof
IL319382A (en) Pharmaceutical preparation and its use
EP4364735A4 (en) PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3998058A4 (en) COSMETIC COMPOSITION CONTAINING 5-BENZYLAMINOSALICYLIC ACID DERIVATIVE AND METHOD FOR TOPICAL ADMINISTRATION
PL2149374T3 (pl) Kompozycja farmaceutyczna zawierająca kombinację środka przeciwdrobnoustrojowego cyprofloksacyny i środka przeciwutleniającego kwasu askorbinowego do leczenia infekcji układu moczowego
EP4559483A4 (en) Hyaluronic acid derivative drug composition and drug composition
HK40116696A (zh) 药物组合物及其用途
HK40110967A (zh) 药物组合物及其用途
AU2020902309A0 (en) Cannabidiol usage in Veterinary Medicine
HK40099664A (en) Pharmaceutical composition and use thereof
AU2020902342A0 (en) Cannabidiol usage in Veterinary Medicine applicant